会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 78. 发明申请
    • DEUTERATED BENZO[D][1,3]-DIOXOL DERIVATIVES
    • DEUTERATED BENZO [D] [1,3] -DIOXOL DERIVATIVES
    • US20140018390A1
    • 2014-01-16
    • US13901651
    • 2013-05-24
    • Roger D. Tung
    • Roger D. Tung
    • C07D405/12
    • A61K31/4525C07D317/64C07D405/12
    • The present invention relates to an isotopologue of Compound 1 substituted with deuterium at the methylene carbon of the benzodioxol ring. The isotopologues of this invention selective serotonin reuptake inhibitors (SSRIs) and possess unique biopharmaceutical and metabolic properties compared to Compound 1. They may also be used to accurately determine the concentration of Compound 1 in biological fluids and to determine metabolic patterns of Compound 1 and its isotopologues. The invention further provides compositions comprising these deuterated isotopologues and methods of treating diseases and conditions that are responsive to increased neuronal serotonin transmission, alone and in combination with additional agents.
    • 本发明涉及在苯并二氧杂环戊烯的亚甲基碳上被氘取代的化合物1的同位素学。 本发明的同位素学选择性5-羟色胺再摄取抑制剂(SSRIs)并且与化合物1相比具有独特的生物药物和代谢性质。它们还可用于精确测定化合物1在生物流体中的浓度并确定化合物1及其化合物1的代谢模式 同位素学。 本发明还提供包含这些氘代同位素异构体的组合物和治疗对增加的神经元血清素传递起反应的疾病和病症的方法,其单独和与另外的试剂组合。
    • 80. 发明授权
    • Deuterated benzo[D][1,3]-dioxol derivatives
    • 氘代苯并[D] [1,3] - 二氧杂环戊烯衍生物
    • US08450492B2
    • 2013-05-28
    • US12688466
    • 2010-01-15
    • Roger Tung
    • Roger Tung
    • C07D211/22
    • A61K31/4525C07D317/64C07D405/12
    • The present invention relates to an isotopologue of Compound 1 substituted with deuterium at the methylene carbon of the benzodioxol ring. The isotopologues of this invention selective serotonin reuptake inhibitors (SSRIs) and possess unique biopharmaceutical and metabolic properties compared to Compound 1. They may also be used to accurately determine the concentration of Compound 1 in biological fluids and to determine metabolic patterns of Compound 1 and its isotopologues. The invention further provides compositions comprising these deuterated isotopologues and methods of treating diseases and conditions that are responsive to increased neuronal serotonin transmission, alone and in combination with additional agents.
    • 本发明涉及在苯并二氧杂环戊烯的亚甲基碳上被氘取代的化合物1的同位素学。 本发明的同位素学选择性5-羟色胺再摄取抑制剂(SSRIs)并且与化合物1相比具有独特的生物药物和代谢性质。它们还可用于精确测定化合物1在生物流体中的浓度并确定化合物1及其化合物1的代谢模式 同位素学。 本发明还提供包含这些氘代同位素异构体的组合物和治疗对增加的神经元血清素传递起反应的疾病和病症的方法,其单独和与另外的试剂组合。